To determine the tumor immunotherapeutic potential of such an approach in vivo, a murine squamous cell carcinoma (SCC 7.1) model, which is dependent on cytotoxic CD8+ T cells for clearance and resolution,33 was used. Here, CD8A is linked to squamous cell carcinoma.